James Patrick Allison
1,116 works · 119,766 citations · h-index 157
Top works
- Enhancement of Antitumor Immunity by CTLA-4 Blockade
- Restoring function in exhausted CD8 T cells during chronic viral infection
- Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
- CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
- Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.
- The future of immune checkpoint therapy
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
- Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
- Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
- The Emerging Role of CTLA-4 as an Immune Attenuator
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- The mouse T cell receptor: Structural heterogeneity of molecules of normal T cells defined by Xenoantiserum
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
- CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting